TOS.TO - TSO3 Inc.

Toronto - Toronto Delayed Price. Currency in CAD

TSO3 Inc.

2505, Avenue Dalton
Quebec, QC G1P 3S5

IndustryMedical Instruments & Supplies
Full Time Employees51

Key Executives

NameTitlePayExercisedYear Born
Mr. Richard M. RumblePres, CEO & Director411.57kN/A1959
Mr. Glen KayllChief Financial Officer238.44kN/A1969
Mr. Harold R. TessmanChief Operations Officer229.06kN/AN/A
Dr. Bradley J. Catalone MBA, Ph.D.Chief Scientific Officer231.83kN/AN/A
Ms. Cindy ClarkSr. VP of Global Commercialization235kN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices worldwide. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. In addition, it offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices. TSO3 Inc. was founded in 1998 and is headquartered in Quebec, Canada.

Corporate Governance

TSO3 Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.